AeroVironment Inc Q1 FY2027 earnings call

• Record Financials: Achieved record first-quarter revenue of $480 million and adjusted EBITDA of nearly $46 million (CFO stated $53 million). Funded backlog reached a record $1.5 billion, up 37% year-over-year.
• Major Contract Wins: Secured landmark awards including a nearly $465 million production contract for the Locust directed-energy system under the Army’s EHEL program, a $500 million IDIQ for the Titan RF jammer, and an $117 million award for the P550 ISR system.
• Capacity Expansion: Announced significant investments to scale manufacturing, including a $100 million innovation center in Southern California, expansions in Albuquerque (Locust), Huntsville (Freedom Eagle One), and a new facility in Salt Lake City for loitering munitions.
• Strategic Direction: Emphasized a shift toward high-volume, firm-fixed-price contracts to improve margins, particularly in the SEDE segment. Highlighted the inflection point for directed energy systems as a cost-effective solution against drone threats.
• International Growth: Noted strong international demand for Switchblade and Puma systems, with approvals in approximately 20 countries. Established joint ventures in Greece and presence in the UK and Turkey to support local content requirements.

The Autonomous Systems (AXS) segment reported revenue of $346 million, representing 72% of total company revenue and a 21% year-over-year increase. The Space, Cyber, and Directed Energy (SEDE) segment reported revenue of $134 million (approximated as $134.5 million in remarks), representing 28% of total company revenue and a 21% year-over-year decrease due to the termination of the SCAR contract and other discontinued programs.

• Revenue: Reaffirmed fiscal year 2027 guidance of $2.125 billion to $2.225 billion.
• Adjusted EBITDA: Reaffirmed fiscal year 2027 guidance of $305 million to $325 million.
• Non-GAAP EPS: Maintained guidance of $3.02 to $3.34 per share.
• Cadence: Expects a 45-55 revenue split between the first and second halves of the year, with EBITDA skewed heavily toward the second half (roughly one-third in H1, two-thirds in H2).
• Expenses: Projected R&D at 7-9% of revenue and Adjusted SG&A at 14-16% of revenue. Capital expenditures targeted at 12-14% of revenue to fund capacity expansion.

• Budget Timing Uncertainty: Potential delays in U.S. Congress approving the fiscal year 2027 budget due to election-year politics, though management does not expect this to impact current guidance.
• Service Margin Pressure: Lower service gross margins (8%) driven by fixed cost absorption issues following the SCAR contract termination and other program losses.
• Supply Chain Scaling: The directed energy supply chain is young; scaling subsystem suppliers and managing long-lead items for the Locust system requires careful execution.
• Free Cash Flow: Expected negative free cash flow for fiscal year 2027 due to increased capital expenditures for facility expansions.

Q: How should investors view Locust profitability and margin trajectory? / A: Management described it as an inflection year where margins will significantly improve as higher-volume firm-fixed-price contracts take over. They expect the SEDE segment's margin profile to eventually match the autonomous systems segment, driven by volume growth and commercialization of direct energy systems.

Q: What is the size of the international market for laser weapons compared to domestic sales? / A: Management believes the international market will be equivalent in size, if not larger, than the domestic market. They cited urgent needs in Eastern Europe, the Middle East, and Asia Pacific, noting that traditional missile defenses are economically unsustainable against cheap drones, creating a multi-billion dollar opportunity for directed energy solutions.

Q: Why was Q2 expected to have lower EBITDA despite revenue growth? / A: The step-down is attributed to sales mix and increased R&D expenses. While volume increases, the mix in Q2 is slightly less favorable than Q1, and R&D costs are expected to tick up, impacting the operating leverage in the second quarter before improving in the back half of the year.

Q: How do tariffs impact AV’s business and supply chain? / A: Management views tariffs positively, stating that over 98% of their supply chain is domestic. They do not rely on Chinese imports for critical systems, relying instead on allies like Canada, Germany, and Israel for the remaining small percentage, positioning them well against import restrictions.

Q: What is the status of the Freedom Eagle One (FE1) kinetic intercept program? / A: The U.S. Army requested an accelerated schedule due to urgent operational needs, supported by additional congressional funding. AV is currently in rapid testing and certification, expecting to deliver 60-80 systems in the next 12-18 months before moving to low-rate and then full-rate production, aiming for a billion-dollar long-term franchise.